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INTRODUCTION
The  Sox  proteins  comprise  a  group  of  transcrip-
tion  factors  that  act  as  key  regulators  of  cell  fate 
decisions in diverse developmental events (Pevny 
and  Lovell-Badge,  1997;  Wegner,  1999; 
Kamachi  et  al.,  2000).  Sox  transcription  fac-
tors  show  both  classical  and  architectural  modes 
of  action  (Pevny  and  Lovell-Badge,  1997), 
either activating or repressing specific target genes 
through interaction with different partner proteins 
in a manner highly dependent on cell type and pro-
moter  context  (Kamachi  et  al.,  2000;  Wilson 
and  Koopman,  2002).  They  are  characterized 
by the presence of a DNA-binding HMG domain 
(Pevny  and  Lovell-Badge,  1997;  Wegner, 
1999) and classified into 10 groups (A - J) according 
to characteristics of the HMG domain and extra-
HMG domain sequences (Bowles et al., 2000).
Together with Sox1 and Sox2, Sox3 belongs to 
the  SoxB1  subgroup  of  transcriptional  activators 
(Kamachi et al., 1995; Kamachi et al., 1998; 
Uchikawa et al., 1999; Kamachi et al., 2000) 
that  are  expressed  by  proliferating  progenitors  of 
the  developing  CNS  (Uwanogho  et  al.,  1995; 
Collignon  et  al.,  1996;  Penzel  et  al.,  1997; 
Uchikawa et al., 1999; Wood and Episkopou, 
1999).  The  Sox3/SOX3  gene  is  implicated  in  the 
control of nervous system development and is con-
sidered to be one of the earliest neural markers in 
vertebrates,  playing  a  role  in  specifying  neuronal 
fate (Brunelli et al., 2003). Chick Sox1, Sox2 and 
Sox3 are critical determinants of neurogenesis, keep-
ing  neural  cells  undifferentiated  by  counteracting 
the activity of proneural proteins (Bylund et al., 
2003).
Evidence for developmental importance of the 
SOX3 gene also comes from mutational analysis in 
humans.  Mutations  in  the  SOX3  gene  are  associ-
ated with X-linked mental retardation with growth 
hormone deficiency (Laumonnier et al., 2002). 
Furthermore,  Woods  et  al.  (2005)  showed  that 
SOX3 is critical for normal development of the hypo-
thalamopituitary axis in humans. Both overdosage 
(by duplication) and underdosage (by poly-alanine 
tract expansion) cause infundibular hypoplasia and 
hypopituitarism (Woods et al., 2005). 
We previously cloned and functionally charac-
terized  the  human  SOX3  promoter.  At  that  times 
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we determined the transcriptional start point (tsp), 
basal promoter region, positive regulatory elements 
necessary for its optimal promoter activity, and some 
transcription  factors  involved  in  regulation  of  its 
expression (Kovacevic-Grujicic et al., 2005). 
We further showed that the TATA box, Sp1, USF, 
and NF-Y binding sites within the basal promoter 
of the human SOX3 gene are of functional impor-
tance for its constitutive expression in embryonal 
carcinoma NT2/D1 cells (Kovacevic-Grujicic 
et al., 2005). Additionally, we showed that the SOX3 
gene is up-regulated during RA-induced neuronal 
differentiation of pluripotental embryonal carcino-
ma  (EC) cell line NT2/D1 (Stevanovic, 2003). 
We  also  demonstrated  that  an  atypical  RA/RXRα 
response element and multiple CCAAT box control 
elements  are,  at  least  in  part,  responsible  for  up-
regulation of SOX3 gene expression (Mojsin et al., 
2006; Krstic et al., 2007). Despite the studies men-
tioned above, only a limited number of transcription 
factors that interact with the SOX3 promoter region 
have been identified and functionally characterized 
so far, and little is known about its developmental 
and tissue-specific regulation of expression.
Myc-associated  zinc  finger  protein  (MAZ)  is 
a  transcription  factor  that  contains  a  proline-rich 
domain, three poly-alanine repeats, and six C2H2-
type zinc finger motifs (Bossone et al., 1992). It 
was first identified as a transcription factor bound 
to the c-myc gene both at the GA box (GGGAGGG) 
of the ME1a1 site and at the P2 attenuator region 
within  the  first  exon  of  this  gene,  as  well  as  to 
a  sequence  that  is  involved  in  the  termination 
of  transcription  of  the  complement  2  gene  (C2) 
(Bossone et al., 1992). MAZ plays a role in con-
trol of the initiation of transcription of genes for the 
adenovirus major late protein (Parks and Shenk, 
1997), CD4 (Duncan et al., 1995), the serotonin 
1a receptor (Parks and Shenk, 1996), and the 
hematopoietic transcription factor (Bockamp et 
al.,  1995).  Additionally  MAZ  is  involved  in  ter-
mination  of  transcription  between  closely  spaced 
human  complement  genes  and  in  termination  of 
transcription within the intron of the mouse IgM-D 
gene (Ashfield et al., 1994). Thus, MAZ appears 
to be a transcription factor with a dual role in the 
initiation and termination of transcription. MAZ is 
expressed ubiquitously but at different levels in dif-
ferent human tissues, and its expression appears to 
be regulated in a cell cycle-dependent manner by the 
MAZ protein itself (Song et al., 1998).
We here establish that the human SOX3 promoter 
region contains three putative binding sites for MAZ 
that are conserved among primates. Additionally, we 
demonstrate that two out of three potential MAZ-
binding sites within the human SOX3 promoter can 
specifically bind MAZ protein present in NT2/D1 
nuclear extracts. Furthermore, we show that exog-
enously added MAZ leads to an increase in SOX3 
promoter activity in both undifferentiated and RA-
differentiated NT2/D1 cells.
MATERIALS AND METHODS
In silico analysis of SOX3/Sox3 promoter regions
The  MatInspector  Release  7.4.5  professional 
program  (http://www.genomatix.de/cgi-bin/matin-
spector_prof/mat_fam.pl)  was  used  to  search  the 
matrix family library database to identify putative 
MAZ binding sites in the human SOX3 promoter 
region spanning the nucleotides -427 to +286 rela-
tive to tsp. Sequence alignments of the correspond-
ing SOX3/Sox3 promoter regions between human, 
chimpanzee, rhesus macaque, rat and mouse were 
performed using ClustalW software (EMBL-EBI).
Preparation of nuclear extracts and bacterially ex-
pressed recombinant protein
Nuclear  extracts  from  uninduced  and  RA-
induced  NT2/D1  cells  were  prepared  according 
to  standard  procedure  (Dignam  et  al.,  1983). 
The  recombinant  GST-MAZ  fusion  protein  was 
expressed  in  the  BL21  E.  coli  strain  and  purified 
following  manufacturer  instructions  (Amersham 
Pharmacia).
Electrophoretic mobility shift analysis
The  following  oligonucleotides  were  used  in 
EMSA and supershift studies:
F M1 - 5’ TTGCGTGCCCCCTCCCCCCTCCCCC
CGTCACCTC 3’ (-321) HUMAN SOX3 PROMOTER TRANS-ACTIVATION BY MAZ 381
R M1 - 5’ GGAGGTGACGGGGGGAGGGGGGAG
GGGGCACGCAA 3’ (-287) 
F M2 - 5’ CTCCGGGTTGCGAGGGGCGGACCA
AGCCCCAA 3’ (-63) 
R M2 - 5’ GGGTTGGGGCTTGGTCCGCCCCTCG
CAACCCGGAG 3’ (-29)
F M3 - 5’ GCTCCAGCCCCGGGAGCG 3’ (+190)
R  M3  -  5’  GAGTTCAGTCTCCAGAAGGCTG  3’ 
(+279) 
The positions of 5’ ends of primers are num-
bered relative to tsp. EMSA probes M1 and M2 were 
generated by annealing corresponding forward (F) 
and  reverse  (R)  oligonucleotides.  Since  R  oligos 
contained 1-3 unpaired G nucleotides at the 5’ ends, 
double-stranded  oligonucleotides  were  labeled  by 
the fill-in reaction using the Klenow fragment and 
[α-32P] dCTP. The M3 probe was generated by PCR 
using corresponding primers and end-labeled with 
T4 polynucleotide kinase and [γ-32P] ATP.
For EMSA experiments, a weighed portion (840 
ng) of recombinant MAZ protein or 2.5 μg of nuclear 
extracts prepared from uninduced and RA-induced 
NT2/D1 cells was incubated for 30 min at 37˚C with 
1 ng (M1 or M2) or 4.6 ng (M3) of 32P-labeled oli-
gonucleotide probes in a binding buffer consisting 
of 10 mM HEPES (pH 7.9), 15 mM KCl, 0.25 mM 
EDTA, 0.25 mM ZnSO4, 3% glycerol, 0.25 mM DTT, 
and 50 ng/μl of poly (dI-dC) in a total volume of 20 
μl. In the supershift assays, 4 μg of antibody against 
MAZ (kindly supplied by Dr. Kenneth B. Marcu) 
was added to the reaction mixtures and incubated 
for 30 min at room temperature before addition of 
the corresponding probes.
Cell culture, transfection, and reporter gene analysis
NT2/D1  cells  were  maintained  as  described 
elsewhere  (Andrews,  1984).  For  each  transfec-
tion, a total of 1.2 × 106 NT2/D1 cells were seeded 
into a 10-cm dish and 5 μg of the F19R30 SOX3 
promoter reporter construct, together with 5 μg of 
empty pCDNA3 (Invitrogen) or the pCDNA3-MAZ 
expression vector and 3 μg of the pCH110 vector 
(Amersham Pharmacia Biotech), were cotransfected 
using the calcium phosphate precipitation method 
as described by Nikcevic et al. (2006). On the fol-
lowing day, the cells were induced by 10 μM all-trans 
RA (Sigma) for 48 h. The pCH110 vector expressing 
β-gal was used to adjust for differences in transfec-
tion  efficiency.  β-gal  and  CAT  assays  were  per-
formed  as  described  by  Kovacevic-Grujicic 
et al. (2005). Normalized CAT activities were calcu-
lated as percentages of the F19R30 construct activity 
in uninduced NT2/D1 cells transfected with empty 
pCDNA3 (which was set as 100%) and are presented 
as  the  means  ±  SD  of  four  independent  experi-
ments. Mean values of relative CAT activities were 
compared with the paired sample t-test (Microsoft 
Excel) and a p value of less than 0.05 was considered 
significant.
RESULTS
The human SOX3 promoter region contains three 
putative MAZ-binding sites
Previous  in  silico  analysis  of  SOX3  promoters 
in mammalian orthologs revealed many conserved 
putative binding sites for various transcription fac-
tors, including MAZ (Kovacevic-Grujicic et 
al.,  2007).  As  shown  in  Fig.  1A,  MatInspector 
analysis revealed three putative MAZ-binding sites 
within the optimal promoter region of the human 
SOX3 gene positioned from -304 to -301 (annotated 
as MAZ 1), -52 to -49 (annotated as MAZ 2), and 
+213 to +216 (annotated as MAZ 3) relative to tsp. 
Comparative analysis of these putative human SOX3 
regulatory  regions  with  corresponding  flanking 
sequences from chimpanzee (Pan troglodytes) and 
rhesus macaque (Macaca mullata) revealed that all 
three putative MAZ-binding sites are conserved with 
respect to their positions (Fig. 1A), while MAZ 2 and 
3 are conserved with respect to the sequence as well. 
Within the analyzed primate promoter sequences, 
a single nucleotide substitution was detected in the 
rhesus macaque sequence homologous to MAZ 1 
(Fig. 1A). Although the analyzed MAZ-binding sites 
from  various  promoters  are  characterized  by  the 
sequence CCCTCCC or GGGAGGG (Bossone et 
al., 1992; Des Jardins and Hay, 1993; Duncan 
et al., 1995; Okamoto et al., 2002), it has also been 
reported that MAZ is able to bind to other GC rich NATAŠA KOVAČEVIĆ-GRUJIČIĆ ET AL. 382
sequences such as CCGCCC (Song et al., 2001). 
Accordingly, it is very likely that the same sequence 
present  in  the  putative  MAZ  1  site  of  the  rhesus 
macaque Sox3 promoter might be functional.
While putative MAZ 1, 2, and 3 are conserved 
in  both  position  and  sequence  among  primates, 
MatInspector analysis showed that only the putative 
MAZ 1 site is preserved with respect to its position 
and sequence in rat (Rattus norvegicus) and mouse 
(Mus musculus) Sox3 promoter regions (Fig. 1A and 
B). The rodent putative MAZ 1 site is positioned 
three  nucleotides  downstream  from  the  primate 
MAZ 1 site (Fig. 1A). Although the MatInspector 
program did not recognize the presence of two other 
MAZ-binding  sites  in  the  rodent  Sox3  promoter 
regions that would correspond to putative MAZ 2 
and MAZ 3 in primates, alignment analysis showed 
100%  nucleotide  identity  within  the  core  MAZ-
binding sites of corresponding regions in primates 
and rodents (Fig. 1A). The observed conservation 
of MAZ-binding sites within Sox3/SOX3 promoter 
Fig. 1. (A) Alignment of mammalian SOX3/Sox3 promoter regions containing putative MAZ binding sites predicted by 
MatInspector. Numbers above the alignment indicate the end positions of the presented SOX3 promoter regions relative 
to tsp. Putative core MAZ-binding sites in the human SOX3 promoter are underlined by solid lines and their positions 
relative to tsp are indicated. Putative core MAZ-binding sites in rodent Sox3 promoter regions are underlined by a dotted 
line. (B) Schematic overview of the putative MAZ-binding sites predicted by the MatInspector program in SOX3/Sox3 
promoter regions of man (Homo sapiens), chimpanzee (Pan troglodytes), rhesus macaque (Macaca mullata), rat (Rattus 
norvegicus), and mouse (Mus musculus). + denotes the presence of putative MAZ-binding site.HUMAN SOX3 PROMOTER TRANS-ACTIVATION BY MAZ 383
regions  in  mammals  suggests  the  existence  of  a 
common transcriptional regulatory mechanism that 
relies on this transcription factor.
Binding of the MAZ transcription factor to putative 
binding sites in the human SOX3 promoter
Since putative transcription factor-binding sites 
that have high core similarity and are located within 
conserved  regions  could  have  relevance  in  tran-
scriptional regulation, we chose to investigate the 
role of the MAZ transcription factor in transcrip-
tional regulation of human SOX3 gene expression. 
To judge from MatInspector and alignment analy-
sis, we generated oligonucleotide probes M1 (-321 
to -287 relative to tsp), M2 (-63 to -29), and M3 
(+190 to +279) that include the predicted conserved 
MAZ-binding  sites  from  the  human  SOX3  pro-
Fig. 2. EMSA with oligonucleotide probes containing putative MAZ binding sites from the human SOX3 promoter. (A) 
EMSAs were performed with radioactively labeled probes M1, M2 and M3 and nuclear extracts from untreated (lanes 
2, 4, 7, 9, 12, and 14) and RA-treated (lanes 3, 5, 8, 10, 13 and 15) NT2/D1 cells. Supershift analyses were performed 
by adding anti-MAZ antibody (lanes 4, 5, 9, 10, 14, and 15). Supershifted complexes (SS) are marked with arrows. (B) 
EMSAs were performed with radioactively labeled probes M1 and M3 and recombinant MAZ protein (lanes 2, 3, 5, and 
6). Supershift analyses were performed by adding anti-MAZ antibody (lanes 3 and 6). Supershifted complexes (SS) are 
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moter region. In order to test whether these regions 
specifically interact with nuclear proteins prepared 
from uninduced and RA-induced NT2/D1 cells, we 
performed electrophoretic mobility shift assay. As 
shown in Fig. 2A, incubation of all three probes with 
nuclear extracts resulted in the appearance of several 
complexes (Fig. 2A, lanes 2, 3, 7, 8, 12, and 13). The 
shifted complexes gave the same binding patterns 
with nuclear extracts prepared from both stem and 
RA-induced NT2/D1 cells.
In order to test the presence of MAZ in pro-
tein/DNA  complexes,  we  used  antibody  against 
MAZ.  Addition  of  this  specific  antibody  resulted 
in  the  formation  of  supershifted  complexes  with 
probes M1 and M3 (SS, Fig. 2A, lanes 4, 5, 14, and 
15), but not with the M2 probe (Fig. 2A, lanes 9 and 
10). In addition, the ability of probes M1 and M3 
to bind MAZ was further confirmed by using puri-
fied recombinant MAZ protein (Fig. 2B, lanes 2 and 
5). Complexes obtained by binding of recombinant 
MAZ were completely supershifted in the presence of 
antibody against MAZ (Fig. 2B, lanes 3 and 6). From 
these experiments we conclude that both recombi-
nant and endogenous MAZ specifically interact with 
probes M1 and M3 containing putative MAZ bind-
ing sites from the human SOX3 promoter.
Fig. 3. Effect of MAZ overexpression on SOX3 promoter activity. NT2/D1 cells were transiently 
cotransfected with the F19R30 SOX3 promoter construct together with either empty pCDNA3 
or the pCDNA3-MAZ expression vector. Normalized CAT activities were calculated as percent-
ages of the F19R30 activity in uninduced NT2/D1 cells transfected with empty pCDNA3 (which 
was set as 100%) and are presented as the means ± SD of four independent experiments. Mean 
values of relative CAT activities were compared with the paired sample t-test (Microsoft Excel). 
Values of p < 0.05 are indicated by asterisks.HUMAN SOX3 PROMOTER TRANS-ACTIVATION BY MAZ 385
It  is  interesting  to  point  out  that  while  the 
MatInspector program predicted a potential MAZ-
binding site within the M2 probe (-63 to -29) of the 
human SOX3 promoter, anti-MAZ antibody failed 
to detect the presence of MAZ in formed DNA/pro-
tein complexes. This result shows that MAZ protein 
cannot recognize the predicted MAZ 2 binding site 
within the SOX3 promoter.
Trans-activation of the human SOX3 promoter by 
MAZ in NT2/D1 cells
Since  we  demonstrated  specific  MAZ  binding 
to  two  conserved  binding  sites  within  the  SOX3 
promoter,  we  wanted  to  test  the  effect  of  MAZ 
overexpression on SOX3 promoter activity in NT2/
D1 cells. Accordingly, a pCDNA3-MAZ expression 
vector containing a full-length coding sequence of 
the  human  MAZ  protein  was  cotransfected  with 
the  F19R30  SOX3  promoter  construct  (spanning 
the  sequence  from  -427  to  +286  relative  to  tsp) 
(Kovacevic-Grujicic et al., 2005) into NT2/
D1 cells. 
We  previously  found  that  neural  induction  of 
NT2/D1 cells by RA is accompanied by up-regula-
tion of SOX3 gene expression at both the mRNA 
and protein levels (Stevanovic, 2003; Mojsin 
et al., 2006). It was previously reported that MAZ 
is  essential  for  ME1a1  site-mediated  expression 
of  the  c-myc  gene  during  neuroectodermal  dif-
ferentiation of mouse P19 EC cells (Komatsu et 
al., 1997). Furthermore, Okamoto et al., (2002) 
identified a GC-rich element within promoter of N-
methyl-D-aspartate (NMDA) receptor subunit type 
1 (NR1) which is recognized by MAZ and Sp1 and 
is responsible for induction of this promoter during 
neuronal  differentiation  of  P19  cells.  Accordingly, 
in order to investigate the potential role of MAZ in 
SOX3 up-regulation during neuronal differentiation 
of NT2/D1 cells, we also analyzed the effect of MAZ 
overexpression  on  SOX3  promoter  activity  in  the 
presence of 10 µM RA.
As shown in Fig. 3, activity of the F19R30 SOX3 
promoter construct is increased approximately 3.0-
fold in RA-treated versus untreated NT2/D1 cells 
(lane 2 versus 1), which is in accordance with data 
obtained  previously  for  this  SOX3  promoter  con-
struct (Krstic et al., 2007). Trans-activation of the 
human SOX3 promoter by MAZ was demonstrated 
in both uninduced and RA-induced NT2/D1 cells. 
Overexpression of MAZ led to 1.7-fold increase of 
SOX3 promoter activity in untreated (lane 3 versus 
1, Fig. 3) and 1.5-fold increase in RA-treated (lane 4 
versus 2, Fig. 3) NT2/D1 cells. Taken together, our 
results point to MAZ as a positive regulator of SOX3 
gene  transcription  in  both  undifferentiated  and 
RA-differentiated  NT2/D1  cells.  Although  MAZ 
increased  both  basal  and  RA-induced  promoter 
activity, the factor of RA induction in the absence or 
presence of exogenously added MAZ (lane 2 versus 
1 and lane 4 versus 3, Fig. 3) remained approximate-
ly the same, suggesting that MAZ does not contrib-
ute to RA inducibility of the SOX3 promoter during 
neuronal differentiation of NT2/D1 cells.
In conclusion, the data presented in this paper 
suggest  that  MAZ  up-regulates  SOX3  promoter 
activity through conserved binding sites within the 
SOX3  promoter  region.  Further  experiments  are 
needed in order to determine if MAZ acts through 
a single (MAZ 1 or 3) or both (MAZ 1/3) putative-
MAZ binding sites identified and characterized in 
this study. Although the mechanism underlying this 
activation remains to be established, the ability of 
MAZ to act as an activator probably reflects its inter-
action with other, not yet identified, transcriptional 
factors involved in development and tissue-specific 
regulation of SOX3 gene expression.
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У овом раду проучавана је улога три високо 
конзервисана  потенцијална  места  везивања  за 
“Myc-associated zinc finger protein” (MAZ) у регу-
лацији експресије хуманог SOX3 гена. Есејиизме- Есеји изме-
њене електрофоретске покретљивости у прису-
ству антитела на  MAZ указују да комплекси који MAZ указују да комплекси који  указују да комплекси који 
се формирају на два од три проучавана места у 
оквиру SOX3 3 промотора садрже MAZ протеин. MAZ протеин.  протеин. 
Такође,  у  експериментима  котрансфекције  смо 
показали да MAZ има улогу позитивног регула- MAZ има улогу позитивног регула-  има улогу позитивног регула-
тора транскрипције SOX3 3 гена, како у недифе-
ренцираним, тако и у диференцираним NT2/D1 NT2/D1 2/D1 D1 1 
ћелијама. Иако је MAZповећаоибазалнуирети- MAZповећаоибазалнуирети-  повећао и базалну и рети-
ноичном  киселином  индуковану  промоторску 
активност, наши резултати указују да овај тран-
скрипциони фактор не доприноси индуцибилно-
сти SOX3 3 промотора током неуралне диференци-
јације у присуству ретиноичне киселине. 